FDA recalls 300,000 Teva blood pressure patches over unapproved ingredient

The Class II recall covers 3 dosages of clonidine transdermal patches made by Actavis Laboratories, with no adverse health ...
The Healthy @Reader's Digest on MSN

300,000 cartons of blood pressure medicine recalled nationwide for 'unapproved' formulation

Both the delivery system and cited defect are relatively unusual—here's what we know.
Nasdaq

FDA Grants Nutriband Meeting Request for Aversa™ Fentanyl Abuse Deterrent Fentanyl Patch

FDA grants meeting for AVERSA™ FENTANYL (abuse deterrent transdermal system) to provide feedback on the Chemistry, Manufacturing, and Controls plans for the product through commercialization.
WCBD

Nutriband and Kindeva Complete Commercial Manufacturing Process Scale-up for Aversa™ Fentanyl Abuse Deterrent Fentanyl Patch

Nutriband and Kindeva have completed commercial manufacturing process scale-up for its lead product Aversa™ Fentanyl, an abuse-deterrent fentanyl patch Nutriband is partnering with Kindeva to develop ...

PharmaTher Announces Filing of U.S. Patent Application for its Peptide Microneedle Patch Technology

Patent filing intended to strengthen PharmaTher's peptide formulation capabilities for PharmaPatch™ while complementing PatchPrint™ as part of the Company's broader microneedle patch development and ...
The National Law Review

Global Transdermal Patch Market Size Transdermal Patches Clinical Trials Approved Patches Price Dosage Market Forecast 2030

Delhi, March 17, 2025 (GLOBE NEWSWIRE) -- Global Transdermal Patch Market Opportunity, Patch Dosage, Price & Clinical Trials Insight 2030 Report Highlights & Findings: The global market for ...